本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Bolt Biotherapeutics, Inc.

3.95
+0.22005.90%
盤後3.950.00000.00%19:30 EDT
成交量:7.71萬
成交額:28.95萬
市值:758.18萬
市盈率:-0.24
高:3.96
開:3.72
低:3.57
收:3.73
52周最高:7.20
52周最低:3.13
股本:191.94萬
流通股本:144.06萬
量比:3.14
換手率:5.35%
股息:- -
股息率:- -
每股收益(TTM):-16.3353
每股收益(LYR):-17.8500
淨資產收益率:-111.65%
總資產收益率:-30.73%
市淨率:0.60
市盈率(LYR):-0.22

資料載入中...

2021/11/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/09

重要事件披露

8-K - Current report
2021/08/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/12

重要事件披露

8-K - Current report
2021/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/02

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/04/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/31

重要事件披露

8-K - Current report
2021/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/19

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/18

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/16

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/11

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/09

重要事件披露

8-K - Current report
2021/02/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/02

SEC問詢函

CORRESP [Cover] - Correspondence